Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy

Afsana Sheikh; Prashant Kesharwani; Waleed H. Almalki; Salem Salman Almujri; Linxin Dai; Zhe-Sheng Chen; Amirhossein Sahebkar; Fei Gao

doi:10.1007/s40820-024-01399-0

Nano-Micro Letters (May 2024)

Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy

Afsana Sheikh,
Prashant Kesharwani,
Waleed H. Almalki,
Salem Salman Almujri,
Linxin Dai,
Zhe-Sheng Chen,
Amirhossein Sahebkar,
Fei Gao

Affiliations

Afsana Sheikh: Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard
Prashant Kesharwani: Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard
Waleed H. Almalki: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Umm Al-Qura University
Salem Salman Almujri: Department of Pharmacology, College of Pharmacy, King Khalid University
Linxin Dai: State Key Laboratory of Southwestern Chinese Medicine Resources, Pharmacy School, Chengdu University of Traditional Chinese Medicine
Zhe-Sheng Chen: Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University
Amirhossein Sahebkar: Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences
Fei Gao: State Key Laboratory of Southwestern Chinese Medicine Resources, Pharmacy School, Chengdu University of Traditional Chinese Medicine

DOI: https://doi.org/10.1007/s40820-024-01399-0
Journal volume & issue: Vol. 16, no. 1
pp. 1 – 56

Abstract

Read online

Highlights Nanoferroptosis: a novel cell death process using various nanoparticles. Therapeutic potential of nanoferroptosis inducers in cancer. Synergistic approach of nanoferroptosis with immunotherapy, sonodynamic and photodynamic therapy.

Published in Nano-Micro Letters

ISSN: 2311-6706 (Print); 2150-5551 (Online)
Publisher: SpringerOpen
Country of publisher: Germany
LCC subjects: Technology
Website: http://www.springer.com/40820

About the journal

Abstract

Keywords